The global demand for Closed System Transfer Devices Market is presumed to reach the market size of nearly USD 4.25 Billion by 2032 from USD 1.71 Billion in 2023 with a CAGR of 10.67% under the study period 2024-2032.
A closed system transfer device is also referred to as the closed system drug-transfer device, mainly used to block the transfer of harmful environmental contaminants into the system. It also controls vapor concentrations of dangerous drugs from leaving the system. Currently, closed system transfer devices mainly deploy two main design concepts: air cleaning technology and physical barrier technology. The rising focus on enhancing the overall safety of healthcare workers responsible for the administration and compounding of harmful drugs is likely to play a crucial role in improving the market over the forecast period.
MARKET DYNAMICS
The market is primarily driven by the rising prevalence of cancer, the increasing number of oncology drug approvals, the growing use of closed system transfer devices to combat the harmful effects of cytotoxic or antineoplastic drugs, and enhancing regulatory guidelines regarding the safe handling and use of hazardous drugs. Further, growing investments in recent years toward developing an efficient drug-handling chain are projected to boost the market's growth. Moreover, the rise in the inclusion of closed system transfer devices in many drug safety programs in conjunction with many other engineering controls is another factor likely to propel the market during the forecast period. However, the high implementation cost, lack of reimbursement, and lack of compliance with regulatory guidelines in the emerging region have restrained the growth globally.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Closed System Transfer Devices. The growth and trends of Closed System Transfer Devices industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Closed System Transfer Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
System (Needle-free Systems, Needle Systems)
Component (Vial Adaptors, Syringe Adaptors, Tubing Sets and Accessories)
By Application
Pharmacy
Nursing
Veterinary
By Distribution Channel
Direct Sales
Distributors
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Closed System Transfer Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Closed System Transfer Devices market include ICU Medical, Baxter, B.Braun, 8D, Equashield, Yukon Medical, Caragen Ltd., JMS Co Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3. CLOSED SYSTEM TRANSFER DEVICES - INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Distribution Channel
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. System (Needle-free Systems, Needle Systems) Historic and Forecast Sales By Regions
5.4. Component (Vial Adaptors, Syringe Adaptors, Tubing Sets and Accessories) Historic and Forecast Sales By Regions
6. GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Pharmacy Historic and Forecast Sales By Regions
6.4. Nursing Historic and Forecast Sales By Regions
6.5. Veterinary Historic and Forecast Sales By Regions
7. GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Direct Sales Historic and Forecast Sales By Regions
7.4. Distributors Historic and Forecast Sales By Regions
8. GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE CLOSED SYSTEM TRANSFER DEVICES COMPANIES
9.1. Closed System Transfer Devices Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF CLOSED SYSTEM TRANSFER DEVICES INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. ICU Medical
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Baxter
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. B.Braun
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. 8D
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Equashield
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Yukon Medical
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Caragen Ltd.
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. JMS Co Ltd
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies